TipRanks

Beth Hecht Insider Profile

11 Followers
Beth Hecht, CLO and Corporate Secretary at Xeris Pharmaceuticals, holds 1.13M shares in Xeris Pharmaceuticals (Ticker: XERS), holds 18.84K shares in Iterum Therapeutics (Ticker: ITRMF), holds 9.05K shares in Aytu BioScience (Ticker: AYTU).
tipranks
Beth Hecht

Beth Hecht
Xeris Pharmaceuticals (XERS)
CLO and Corporate Secretary

Ranked #13,210 out of 109,193 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+46.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$11M
99.82%
0.18%
<0.01%
A breakdown of Beth Hecht's holdings

Insider Roles

Xeris Pharmaceuticals
(XERS)
CLO and Corporate Secretary
Aytu BioScience
(AYTU)
Director
Iterum Therapeutics
(ITRMF)
Director
Roles that Beth Hecht holds in companies

Most Profitable Insider Trade

Stock:
Xeris Pharmaceuticals
(XERS)
Rating:Informative Buy
Date:Mar 16, 2020 - Mar 16, 2021
Return:+200.00%
The most profitable trade made by Beth Hecht

Beth Hecht's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Xeris Pharmaceuticals
Sep 01, 2026
CLO and Corporate Secretary
Uninformative Sell
141.33K
$11.26M
Iterum Therapeutics
Jun 15, 2023
Director
Uninformative Buy
17.60K
$584.01
Aytu BioScience
Apr 12, 2021
Director
Uninformative Buy
―
$19.91K
NEOS
Neos Therapeutics
Mar 19, 2021
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Beth Hecht's performance on stock

Beth Hecht insider profile FAQ

What is the percentage of profitable transactions made by Beth Hecht?
The percentage of profitable transactions made by Beth Hecht is 75%.
    What is the average return per transaction made by Beth Hecht?
    The average return per transaction made by Beth Hecht is 46.20%.
      What stocks does Beth Hecht hold?
      Beth Hecht holds: XERS, ITRMF, AYTU, NEOS stocks.
        What was Beth Hecht’s latest transaction?
        Beth Hecht latest transaction was an Uninformative Sell of $141.33K.
          What was Beth Hecht's most profitable transaction?
          Beth Hecht’s most profitable transaction was an Informative Buy of XERS stock on March 16, 2020. The return on the trade was 200.00%.
            What is Beth Hecht's role in Xeris Pharmaceuticals?
            Beth Hecht's role in Xeris Pharmaceuticals is CLO and Corporate Secretary.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.